A5031970645- Congenital Heart Disease Studies
- Cardiac Arrhythmias and Treatments
- Cardiac Valve Diseases and Treatments
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Cardiac Structural Anomalies and Repair
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias
- Myofascial pain diagnosis and treatment
- Mechanical Circulatory Support Devices
- Cardiac Health and Mental Health
- Nerve Injury and Rehabilitation
- Blood Pressure and Hypertension Studies
- Muscle and Compartmental Disorders
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Osteomyelitis and Bone Disorders Research
- Cardiovascular Issues in Pregnancy
- Scoliosis diagnosis and treatment
- Lipoproteins and Cardiovascular Health
- Cardiac pacing and defibrillation studies
- Heart Rate Variability and Autonomic Control
- Medication Adherence and Compliance
- Renal function and acid-base balance
- Health Systems, Economic Evaluations, Quality of Life
- Kawasaki Disease and Coronary Complications
AHEPA University Hospital
2016-2024
Aristotle University of Thessaloniki
2016-2024
General Hospital Asklepieio Voulas
2014
Achieving low-density lipoprotein cholesterol (LDL-C) target levels after an acute coronary syndrome (ACS) is of paramount importance, and often burdened by undertreatment medication or lifestyle non-adherence issues. We examined the effect a patient-centered, physician-led motivational intervention following ACS on relevant secondary prevention aspects. The IDEAL-LDL single-center, randomized controlled clinical trial, conducted among patients hospitalized due to ACS. Following discharge,...
Introduction The risk for stroke in adults with congenital heart disease (ACHD) is increased, especially the setting of commonly ensuing atrial arrhythmias (AA), namely fibrillation, flutter or intra-atrial re-entrant tachycardia. Data are limited regarding treatment non-vitamin K oral anticoagulants long-term studies involving patients ACHD and AA. Methods analysis PReventiOn ThromboEmbolism Adults Congenital HearΤ Atrial aRrhythmias a prospective, multicenter, single-arm,...
The implications of the adult congenital heart disease anatomic and physiological classification (AP-ACHD) for risk assessment have not been adequately studied. A retrospective cohort study was conducted using data from an ongoing national, multicentre registry patients with ACHD atrial arrhythmias (AA) receiving apixaban (PROTECT-AR study, NCT03854149). At enrollment, were stratified according to Anatomic class (AnatC, range I III) stage (PhyS, B D). follow-up between May 2019 September...
The implications of the adult congenital heart disease anatomic and physiological classification (AP-ACHD) for risk assessment have not been adequately studied. A retrospective cohort study was conducted using data from an ongoing national, multicentre registry patients with ACHD atrial arrhythmias (AA) receiving apixaban (PROTECT-AR study, NCT03854149). At enrollment, were stratified according to Anatomic class (AnatC, range I III) stage (PhyS, B D). Follow-up between May 2019 September...
Background: Considering the increasing burden of cardiovascular risk factors and recent advances on management acute coronary syndromes (ACS), we studied epidemiological characteristics treatment strategies patients presenting with ACS. We also evaluated lipid profile attainment goals in a 'real world' clinical setting.Methods: This was substudy IDEAL-LDL (Motivational interviewing to support low-density lipoprotein cholesterol (LDL-C) therapeutic lipid-lowering therapy compliance...
The Symplicity-HTN 3 trial failed to show significant difference in blood pressure (BP) lowering between patients undergoing catheter-based renal denervation (RDN) and the sham-procedure arm of study. However, there is still optimism about role RDN treatment resistant hypertension, because identification with increased sympathetic activity thus being good responders, improvements procedure new technology catheters are all expected lead better results. We present our initial experience for...
Electrical storm (ES) is not uncommon among patients with an implantable cardioverter defibrillator (ICD) in situ. Catheter ablation (CA) may suppress the arrhythmia acute setting and prevent ES recurrence. Nineteen consecutive ICD situ presenting underwent electrophysiologic studies followed by CA. CA outcome was classified as a complete success if both clinical non-clinical tachycardia were successfully ablated, partial ≥1 episodes still inducible post–CA, failure could be abolished....
The prognostic value of health status metrics in patients with adult congenital heart disease (ACHD) and atrial arrhythmias is unclear. In this retrospective cohort study an ongoing national, multicenter registry (PROTECT-AR, NCT03854149), ACHD on apixaban are included. At baseline, were assessed using the physical component summary (PCS), mental (MCS) Short-Form-36 (SF-36) Health Survey, modified European Heart Rhythm Association (mEHRA) score. Patients divided into groups according to...
Introduction: In adults with congenital heart disease (ACHD), atrial arrhythmias (AA) confer an increased risk of thromboembolic events. Limited data exist on non-vitamin K oral anticoagulant (NOAC) treatment for ACHD. We aimed to assess the effectiveness and safety apixaban in ACHD patients AA. Methods: PROTECT-AR (NCT03854149) was a prospective, multicenter, observational study conducted from 2019 2023. fibrillation, flutter, or intra-atrial re-entrant tachycardia, who were routinely...
Risk assessment in the expanding population of adult patients with congenital heart disease (ACHD) is high importance. To report clinical characteristics, complications, mortality rate and causes death a single-centre ACHD cohort. Data were prospectively collected from an outpatient clinic January 2012 until December 2019. Of 356 (median age 34 years, 52.5% female), 116 (32.6%) classified as simple, 182 (51.1%) moderate 58 (16.3%) complex ACHD. At baseline assessment, more than half (n =...